Trial site
Medical Center Medconsult Pleven OOD
- 21running trials
- 6closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)8 trials
- Hidradenitis suppurativa7 trials
- Chronic spontaneous urticaria4 trials
- Psoriasis4 trials
- Alopecia areata1 trial
- COPD1 trial
- Heart failure1 trial
- IgA nephropathy1 trial
- Multiple sclerosis1 trial
- Vitiligo1 trial
- Phase
- Phase 216 trials
- Phase 311 trials
- Phase 11 trial
- Status
- Recruiting10 trials
- Active, not recruiting9 trials
- Completed6 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Almirall, S.A.2 trials
- Bluefin Biomedicine Inc.2 trials
- Celldex Therapeutics2 trials
- Novartis Pharma AG2 trials
- Takeda2 trials
- and 18 more
Running trials
Recruiting
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
Recruiting
A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa
Active, not recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Recruiting
Recruiting
Recruiting
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Active, not recruiting
Recruiting
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Active, not recruiting
Recruiting
Enrolling by invitation
Recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Not yet recruiting
Active, not recruiting
Recruiting
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)3 recruiting
- Hidradenitis suppurativa3 recruiting
- Chronic spontaneous urticaria2 recruiting
- Alopecia areata1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
- Multiple sclerosis1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Terminated
Terminated
Completed
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026